טוען...
Rituximab-Induced Depletion of Anti-PLA(2)R Autoantibodies Predicts Response in Membranous Nephropathy
Autoantibodies to the M-type phospholipase A(2) receptor (PLA(2)R) are sensitive and specific for idiopathic membranous nephropathy. The anti-B cell agent rituximab is a promising therapy for this disease, but biomarkers of early response to treatment currently do not exist. Here, we investigated wh...
שמור ב:
| Main Authors: | , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society of Nephrology
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3148709/ https://ncbi.nlm.nih.gov/pubmed/21784898 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2010111125 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|